Financials

  • Market Capitalization 6.4 B
  • Employee 103
  • Founded 2018
  • CEO N/A
  • Website www.erasca.com
  • Headquarter Delaware, United States
  • FIGI BBG00MTSR883
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.45
Relación precio/flujo de caja
361.71

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1084
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
108.24 USD-3.81%-1.65%+0.58%-1.88%7.45 B USD
1118
SRRK
Scholar Rock Holding Corporation - Common Stock
57.48 USD-3.00%+2.90%+18.22%+91.47%7.00 B USD
1186
MIRM
Mirum Pharmaceuticals, Inc. - common stock
97.02 USD-2.74%+0.73%-13.41%+38.34%6.30 B USD
1194
TVTX
Travere Therapeutics, Inc. - Common Stock
66.08 USD-2.13%-0.11%+17.89%+129.68%6.23 B USD

Noticias